in vitro — The latest news about safe, sustainable and bio-based materials and products

Vireo Publishes "Characterization of a Human In Vitro Intestinal Model for the Hazard Assessment of Nanomaterials Used in Cancer Immunotherapy"

Vireo, and our co-authors at Baylor University, have published a study advancing the use of alternative testing strategies for nanomaterial safety assessments.

Alternate Testing, Leadership, Nanomaterials, Safety, Nanotechnology, Risk AnalysisJames EdeMarch 1, 2021Vireo Advisors, Baylor University, alternative testing strategies, nanomaterial safety assessments, in vitro, cell-based intestinal model, nanomaterial, nanomaterial hazard assessment, animal testingComment

Intelligence Bulletin Outlines NIOSH’s Approach to Risk Assessment; Addresses Nanomaterials

The National Institute for Occupational Safety and Health (NIOSH) recently published Current Intelligence Bulletin (CIB) 69: NIOSH Practices in Occupational Risk Assessment.

Nanomaterials, Risk Analysis, NanoEHS News, GuidanceJames EdeApril 7, 2020NIOSH, nanomaterials, nanotoxicology, nanomaterial risk assessment, in vitro, in vivoComment

Harvard School of Public Health (HSPH) Publishes "Toxicological effects of ingested nanocellulose in in vitro intestinal epithelium and in vivo rat models "

Researchers at the Harvard School of Public Health (HSPH) have published findings that demonstrate ingested nanocellulose has little acute toxicity when gavaged at low doses.

Nanomaterials, Risk AnalysisJames EdeJune 26, 2019Vireo Advisors, Harvard School of Public Health (HSPH), DeLoid, ingested nanocellulose, purified cellulose fibrils (CNF), cellulose nanocrystals (CNC), Vireo-led Food Safety Study, in vitro, cell triculture model, five-week in vivo feeding study, cellulose nanomaterials in a 90-day feeding study, cellulose nanomaterial safety for food-related applicationsComment

Special issue of Risk Analysis Journal Explores Alternate Testing Strategies for Nanomaterials

Several themes were explored by The Emerging Nanoscale Materials Specialty Group (ENMSG) of the Society for Risk Analysis (SRA) co-organized by Jo Anne Shatkin and Kimberly Ong with a wonderful team of collaborators in a 2014 workshop on the use of alternate testing strategies (ATS) for risk assessment of nanomaterials.

PETA Workshop Furthers Work on Developing Alternate Testing Strategies for Studying the Effects of Nanomaterials in the Lung

A workshop organized by People for the Ethical Treatment of Animals (PETA) Science Consortium Ltd. has led to several publications developing alternate testing strategies (non-animal methods) for studying nanomaterial effects in the lung.

Alternate Testing, NanomaterialsJames EdeJuly 19, 2016PETA, Archives of Toxicology, ATS, Alternative Testing Strategy, Nanomaterials, in vivo, pulmonary fibrosis, in vitro, non-animal testing, Safety, Carbon NanotubesComment